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Chlamydia trachomatis replicates within a mem-
brane-bound compartment termed an inclusion.
The inclusion membrane is modified by the insertion
of multiple proteins known as Incs. In a yeast two-
hybrid screen, an interaction was found between
the inclusion membrane protein CT228 and MYPT1,
a subunit of myosin phosphatase. MYPT1 was re-
cruited peripherally around the inclusion, whereas
the phosphorylated, inactive form was localized to
active Src-family kinase-rich microdomains. Phos-
phorylated myosin light chain 2 (MLC2), myosin light
chain kinase (MLCK), myosin IIA, and myosin IIB also
colocalized with inactive MYPT1. The role of these
proteins was examined in the context of host-cell
exit mechanisms (i.e., cell lysis and extrusion of
intact inclusions). Inhibition of myosin II or small
interfering RNA depletion of myosin IIA, myosin IIB,
MLC2, or MLCK reduced chlamydial extrusion, thus
favoring lytic events as the primary means of release.
These studies provide insights into the regulation of
egress mechanisms by C. trachomatis.
INTRODUCTION
Chlamydiae are Gram-negative obligate intracellular bacteria
that cause a variety of infections in humans and animals.
Chlamydia trachomatis is comprised of multiple serological
variants, or serovars, that are responsible for different diseases.
Among these are the causative agents of the most prevalent
bacterial sexually transmitted disease in the United States
(Schachter, 1999) and the etiological agents of trachoma, the
leading cause of infectious blindness worldwide (Burton and
Mabey, 2009). All chlamydiae share common infection strate-
gies, including a biphasic developmental cycle that consists of
metabolically inactive infectious elementary bodies (EBs) and
metabolically active and noninfectious reticulate bodies (RBs)
(Moulder, 1991). The chlamydial developmental cycle occurs
within a unique parasitophorous vacuole termed an inclusionC(Hackstadt et al., 1997). At the end of the developmental cycle,
EBs are released to initiate new cycles of infection. Release
may be accomplished by lysis of the host cell or extrusion of
intact inclusions by an active process requiring actin polymeriza-
tion (Chin et al., 2012; Hybiske and Stephens, 2007; Todd and
Caldwell, 1985).
The inclusion membrane is the interface for interaction
between chlamydiae and the host cell. Early in infection, the
inclusion membrane is extensively modified by the insertion of
bacterially synthesized, type III secreted proteins, termed inclu-
sion membrane proteins (Incs), that decorate the cytosolic face
of the inclusion (Hackstadt et al., 1999; Rockey et al., 1997; Scid-
more and Hackstadt, 2001). The number of Incs predicted varies
among species, with predictions for C. trachomatis ranging
between 36 and 59 Incs (Bannantine et al., 2000; Dehoux
et al., 2011; Li et al., 2008; Lutter et al., 2012; Shaw et al.,
2000; Toh et al., 2003). These Incs are comprised of a highly
diverse set of proteins that are suspected of being involved in
modulating host signaling pathways and cellular functions.
Virtually all interactions of the chlamydial inclusion with the
eukaryotic host cell require de novo chlamydial protein synthesis
and, presumably, modification of the inclusion membrane
(Scidmore et al., 1996). These functions include acquisition of
host lipids (Carabeo et al., 2003; Hackstadt et al., 1996) and
trafficking to the microtubule organizing center (MTOC), where
the inclusion is typically observed in close proximity to the host
cell nucleus and centrosomes (Clausen et al., 1997; Grieshaber
et al., 2003, 2006; Higashi, 1965; Mital and Hackstadt, 2011;
Mital et al., 2010). There are relatively few confirmed interactions
of host proteins with specific Incs. These include the interactions
of CT229 with Rab4 (Rzomp et al., 2006), IncG (CT118) recruit-
ment of 14-3-3b (Scidmore and Hackstadt, 2001), and IncD
(CT115) interaction with CERT (Derre´ et al., 2011).
In this study, a yeast two-hybrid screen of C. trachomatis Inc
CT228 identified an interaction with myosin phosphatase target
subunit 1 (MYPT1), a subunit of myosin phosphatase. MYPT1
was recruited peripherally around the chlamydial inclusion,
whereas the phosphorylated, inactive form of MYPT1 was
enriched at Src-family kinase-rich microdomains (Mital et al.,
2010) on the inclusion membrane. Phosphorylated myosin light
chain 2 (MLC2), myosin light chain kinase (MLCK), and myosin
IIA and IIB were also identified in the inclusion microdomains.ell Reports 3, 1921–1931, June 27, 2013 ª2013 The Authors 1921
Depletion of myosin IIA, myosin IIB, MLCK, or MLC2 by small
interfering RNA (siRNA) resulted in decreased extrusion forma-
tion by C. trachomatis, suggesting that CT228 functions in
regulation of release mechanisms at the end of the develop-
mental cycle.
RESULTS
Yeast Two-Hybrid Screen of CT228
TheC terminusofCT228downstreamof thebilobedhydrophobic
domain (aminoacids [aa] 86–196; Figure 1A)wascloned intoGal4
DNA binding domain (BD Bioscience) pGBKT7 (Clontech; Fig-
ure 1B) and transformed into yeast strain AH109. To identify
putative interacting partners, AH109 containing pGBKT7-
CT228 was used as bait to screen yeast strain Y187 containing
a random normalized HeLa complementary DNA (cDNA) library
(Clontech). A low-stringency screen was first employed to select
for diploids and the results were confirmed in higher-stringency
conditions on SD-Trp Leu His Ade + X-a-galactosidase plates.
Prey plasmids were isolated and sequenced. One of the positive
diploids identified after the bait dependency tests, Prey-43,
contained the C terminus of the PPP1R12A gene, which
corresponds to the leucine zipper domain ofMYPT1. The interac-
tion between CT228 and MYPT1 was verified in a targeted
screen using in-frame fusions of Gal4AD to full-length MYPT1
(Figure 1C).
Coimmunoprecipitation experiments confirmed the interac-
tion between CT228 and MYPT1 in vivo. MYPT1 was coprecipi-
tated by anti-CT228 in the C. trachomatis L2-infected lysates,
but not in uninfected lysates or by an irrelevant antiserum
(Figure 1D).
To verify the domain of MYPT1 (Figure 1E) interacting with the
C terminus of CT228, full-length and N-terminal truncations of
MYPT1 starting at aa 445, 632, and 845 either with (MYPT1) or
without the leucine zipper (MYPT1DLZ) were fused to Gal4AD
and screened for interaction with CT228 (Figure 1F). The interac-
tion of MYPT1 with the C terminus of CT228 was specific, as
MYPT1 did not interact with the empty vector, pGADT7. The
interaction of CT228 with MYPT1 was limited to the constructs
that contained the leucine zipper, suggesting that the interaction
was specific to that region.
CT228 and MYPT1 Localization to the Inclusion
Membrane
HeLa cell monolayers infected with C. trachomatis L2 for 18 hr
were stained with rabbit anti-CT228 and mouse anti-MOMP or
mouse anti-Src pY419. CT228 was observed around the cir-
cumference of the inclusion membrane but was enriched in
discrete microdomains colocalizing with active Src-family
kinases (Figure 2A).
The distribution of MYPT1 in infected cells was also examined
in C. trachomatis L2-infected HeLa cells. At 18 hr postinfection,
cells were fixed and labeled with polyclonal rabbit anti-MYPT1
and mouse anti-MOMP (Figure 2B). MYPT1 was localized to
the inclusion membrane and not the intracellular bacteria, similar
to patterns previously observed for IncA and IncG (Hackstadt
et al., 1999; Scidmore-Carlson et al., 1999). Dual labeling with
MYPT1 and 14-3-3b, a host cell protein that was previously1922 Cell Reports 3, 1921–1931, June 27, 2013 ª2013 The Authorsshown to be recruited to the inclusion membrane through its
interaction with IncG (Scidmore and Hackstadt, 2001), demon-
strated localization of MYPT1 to the inclusion membrane (Fig-
ure 2B). The recruitment patterns ofMYPT1 to both the periphery
of the inclusion and microdomains matches the localization of
CT228. To confirm the recruitment of MYPT1 to the inclusion
membrane, an N-terminal mCherry fusion of full-length MYPT1
was expressed in C. trachomatis L2-infected HeLa cells. In
HeLa cells expressing mCherry-MYPT1, MYPT1 was recruited
to the periphery of the inclusion membrane in the same pattern
seen with MYPT1 antibodies (Figure 2C). The recruitment of
MYPT1 to the periphery of the inclusion membrane with enrich-
ment at microdomains was corroborated by immunoelectron
microscopy using anti-MYPT1 with immunoperoxidase labeling
to show the diaminobenzidine reaction product at the cytosolic
face of the inclusion membrane (Figure 2D).
MYPT1 Recruitment Is Species Specific
The recruitment of MYPT1 to inclusions of other chlamydial
serovars and chlamydiae species was examined. HeLa cells
were infected with C. muridarum, C. caviae, C. pneumoniae, or
the C. trachomatis serovars A, B, D, or L2, and stained with
chlamydia lipopolysaccharide (LPS) and MYPT1 antibodies.
MYPT1 localized to all C. trachomatis inclusions except serovar
B/Jali20 (Figure 3), which encodes a truncated form of CT228
(Seth-Smith et al., 2009) and does not detectably express
CT228. C. muridarum also recruited MYPT1 to the inclusion
membrane, butC. caviae andC. pneumoniae did not, suggesting
that there are diverse requirements for MYPT1 among the
different chlamydial species and C. trachomatis serovars. The
absence of MYPT1 from serovar B/Jali20, which does not
express CT228, confirms the role of this inclusion membrane
protein in recruitment of MYPT1.
C. trachomatis Infection Induces Phosphorylation
Changes inMYPT1 and Selective Recruitment of pT853-
MYPT1 to Chlamydial Microdomains
CT228 is one of the Incs that are transcribed early in infection
(Belland et al., 2003; Shaw et al., 2000). By 4 hr postinfection,
C. trachomatis has initiatedprotein synthesis andmodified the in-
clusion membrane. Recruitment of MYPT1 is observed by this
time (Figure 4A) and is retained circumferentially around the
inclusion membrane for the duration of the developmental cycle.
MYPT1 is known to be phosphorylated by a number of
kinases, specifically Rho-associated kinase (ROCK) at threo-
nines 853 and 696 (Feng et al., 1999; Kawano et al., 1999).
Phosphorylation of these sites is inhibitory to MYPT1 function
due to tertiary folding changes to MYPT1 that no longer
allow for the binding of the myosin phosphatase complex to
MLC2. Dephosphorylation of MLC2 at threonine 18 and serine
19 by myosin phosphatase is inhibitory to myosin motor
activity, and thus phosphorylation of MYPT1 favors MLC2
activity. Because the phosphorylation state of MYPT1 is
important for activity, the phosphorylation of MYPT1 was inves-
tigated during C. trachomatis infection. Specific antibodies to
MYPT1 phosphorylated at T853 (pT853) or T696 (pT696), as
well as anti-MYPT1, were used to probe immunoblots of
C. trachomatis-infected HeLa cell lysates taken at intervals
Figure 1. Yeast Two-Hybrid Screen and Interaction of
C. trachomatis CT228 with MYPT1
(A) Kyte-Doolittle plot (Kyte and Doolittle, 1982) of CT228 showing
the location of the bilobed hydrophobic domain.
(B) Schematic of bait and prey yeast-two hybrid constructs. The bait
construct was generated by fusing the C terminus of CT228 in frame
with Gal4BD. The interacting prey identified in the screen consisted
of the leucine zipper of MYPT1 fused to Gal4AD (prey 43).
(C) Interactions in the yeast two-hybrid screen were verified by
b-galactosidase assays of S. cerevisiae diploids generated from
mating pairs of pGBKT7 (bait) and pGADT7 (prey) fusions. Liquid
b-galactosidase assays confirmed interactions between the positive
control p53 and T-antigen, CT228 (C terminus) and prey 43 (yeast
two-hybrid prey containing the leucine zipper of MYPT1), and CT228
(C terminus) and full-length MYPT1. No interactions were detected
with CT228 and MYPT1DLZ, pGBKT7 and MYPT1, or pGBKT7 and
MYPT1DLZ, or in the negative control of Lamin and T-antigen.
b-galactosidase activity was determined in triplicate, with error bars
representing SD.
(D) Immunoblot of MYPT1 coimmunoprecipitated from L2-infected
HeLa lysates with rabbit polyclonal antisera to CT228. No interaction
was detected in uninfected HeLa lysates or the negative control
antisera to Rickettsia rickettsii (anti-Rr).
(E) Diagram of myosin phosphatase showing the relevant regulatory
phosphorylation sites on MYPT1, the small subunit (M20), and the
catalytic subunit Protein Phosphatase 1 (PP1). Also shown are the
locations of the ankyrin repeats and the leucine zipper.
(F) Interactions in the yeast two-hybrid screen were verified by
a-galactosidase assays of S. cerevisiae diploids generated from
mating pairs of GBKT7-CT228 and N-terminally truncated MYPT1
Gal4AD fusions (starting at aa 445, 632, or 845; either lacking or
retaining the leucine zipper [a–f]). Diploids were grown in SD-Trp Leu
and interactions were detected on high-stringency SD-Trp Leu His
Ade + a-galactosidase. Interactions were detected between CT228
andMYPT1-Gal4AD fusions containing the leucine zipper (b, d, and f)
as well as the positive control p53 + T-antigen (+). No interactions
were detected with MYPT1-Gal4AD fusions lacking the leucine
zipper (a, c, and e) and the negative control Lamin + T antigen (). AR,
ankyrin repeat; LZ, leucine zipper.
Cell Reports 3, 1921–1931, June 27, 2013 ª2013 The Authors 1923
Figure 2. CT228 and MYPT1 Localization to the C. trachomatis In-
clusion Membrane
(A) HeLa cell monolayers were infected with C. trachomatis L2 at an MOI of
1 for 18 hr. Cells were fixed and labeled with anti-CT228 and anti-MOMP or
anti-Src-pY419. Merged images show CT228 localizing to the periphery of the
inclusion and enriched with active Src kinase. Scale bar, 5 mm.
(B) HeLa cells were infected at an MOI of 1 for 18 hr, fixed, and labeled
with rabbit anti-MYPT1 and mouse anti-C. trachomatis MOMP or mouse
anti-14-3-3b.
(C) Expression of mCherry-MYPT1, showing recruitment to the C. trachomatis
inclusion membrane at 18 hr postinfection. Scale bar, 5 mm (B and C).
(D) Immunoelectron microscopy showing localization of MYPT1 with
enrichment at specific sites in the inclusion membrane. Scale bar, 2 mm.
1924 Cell Reports 3, 1921–1931, June 27, 2013 ª2013 The Authorsthroughout the developmental cycle (Figure 4B). Total MYPT1
levels remained constant in infected and uninfected lysates;
however, by 42 hr postinfection, a dramatic reduction in phos-
phorylation of MYPT1 at both phosphorylation sites (T696 and
T853) was seen in infected cell lysates.
To determine whether there was differential recruitment of the
phosphorylated forms of MYPT1, C. trachomatis L2-infected
HeLa cells were labeled with anti-pT853-MYPT1 and anti-Src-
pY419, and examined by immunofluorescence. Phosphorylated
MYPT1was recruited to the inclusion, but was enriched inmicro-
domains (Figure 4C) rather than circumferentially around the
inclusion membrane as observed with the MYPT1 antibody (Fig-
ures 2 and 4A). The pattern was similar to that previously
described for microdomains that are laden with active Src-family
kinases (Mital et al., 2010). At 18 hr postinfection, pT853-MYPT1
was rarely observed at the microdomains. However, as the
infection progressed, the pT853 form of MYPT1 became more
prominent in the microdomains, suggesting a time-dependent
phosphorylation change or recruitment of pT853-MYPT1 late in
the chlamydial developmental cycle. Collectively, the data sug-
gest thatC. trachomatis infection results in decreased phosphor-
ylation of the inhibitory sites onMYPT1, but selective recruitment
of the remaining pT853-MYPT1 to microdomains on the chla-
mydial inclusion late in development. Thus, the phosphorylation
and activity of MLC2 are expected to be enhanced at these focal
points on the inclusion membrane at the time of egress.
Active MLCK, Serine 19 Phosphorylated MLC2, Myosin
IIA, and Myosin IIB Are Recruited to Microdomains
WhenMYPT1 is phosphorylated at T853, its phosphatase activity
is inhibited and correlateswith increased levels of S19 phosphor-
ylated MLC2. S19-phosphorylated MLC2 interacts with heavy-
chain myosin II. Antagonistic to MYPT1 is MLCK, which actively
phosphorylates MLC2. MLCK activity is also regulated by the
phosphorylation state. Phosphorylation of Y464 (pY464) and
Y471 (pY471) promotes kinase activity (Birukov et al., 2001).
Because the inactive, phosphorylated T853 form of MYPT1 is
recruited to inclusion membrane microdomains that are known
to be areas of active Src-family kinase activity, the potential for
MLCK, pS19-MLC2, and myosin II recruitment was also exam-
ined.C. trachomatisL2-infectedHeLa cellmonolayerswere fixed
and labeled with anti-Src-pY419 and either anti-pS19-
MLC2, anti-pY464-MLCK, anti-pY471-MLCK, anti-myosin IIA,
or myosin IIB (Figure 5). Each of these were enriched at inclusion
microdomains and colocalized with active Src-family kinases.
Figure 3. Species-Specific Recruitment of MYPT1
HeLa cells were infected with C. trachomatis serovars A, B, D, and L2;
C. muridarummouse pneumonitis (MoPn);C. caviae (GPIC); orC. pneumoniae
AR-39 (Cpn). At specific times, cells were fixed (A: 30 hr; B: 30 hr; D: 30 hr; L2:
18 hr; MoPn: 30 hr; GPIC: 30 hr, and Cpn: 48 hr), permeabilized, and labeled
with chlamydia LPS antibody and MYPT1 antibody. Chlamydial serovars and
species grow at different rates. Images were selected to show inclusions
of approximately the same size. MYPT1 recruitment was specific for
C. muridarum and the C. trachomatis serovars A, D, and L2. Scale bar, 5 mm.
Figure 4. Infection by C. trachomatis L2 Causes Phosphorylation
Changes in MYPT1 and Selective Time-Dependent Recruitment of
pT853-MYPT1 in Microdomains
(A) Indirect immunofluorescence of C. trachomatis L2-infected HeLa cells at 4,
12, 24, and 42 hr postinfection at an MOI of 10 stained with MYPT1 (green)
and L2 EB (red) antisera to show early recruitment and retention of MYPT1 to
the inclusion membrane. By 4 hr postinfection, the inclusion membrane has
been modified by insertion of chlamydial protein, and trafficking of nascent
inclusions to the MTOC is evident (Grieshaber et al., 2003). By 12 hr post-
infection, replication of RBs is apparent but the inclusions have not yet fused
into a single inclusion, as is typical of C. trachomatis (Hackstadt et al., 1999).
Scale bar, 10 mm.
(B) Immunoblot analysis of cell lysates infected with C. trachomatis L2 at an
MOI of 5 for 0, 18, 30, and 42 hr showing levels of Pan-MYPT1, pT853-
MYPT1, and pT696-MYPT1.
(C) Indirect immunofluorescence of C. trachomatis L2-infected HeLa cells at
18, 30, and 42 hr postinfection at anMOI of1 stainedwith anti-pT853-MYPT1
(green) and anti-Src-pY419 (red). The lumen of the inclusion (I) is indicated.
Scale bar, 10 mm.C. trachomatis Release by Extrusion Requires MLCK,
MLC2, and Myosin II
Myosin II has been implicated in exit mechanisms of
C. trachomatis at the end of the developmental cycle and isCrequired for extrusion formation by C. trachomatis through the
use of the inhibitor blebbistatin (Hybiske and Stephens, 2007);
therefore, the role of the myosin phosphatase pathway in extru-
sion formation was investigated.ell Reports 3, 1921–1931, June 27, 2013 ª2013 The Authors 1925
Figure 6. Depletion of MLCK, MLC2, Myosin IIA, and Myosin IIB
Inhibits Extrusion Formation
(A) Effect on extrusion production by siRNA depletion of components of the
myosin phosphatase and myosin kinase pathways.
(B) Effect on total infectious progeny production by siRNA depletion of
components of the myosin phosphatase and myosin kinase pathways.
Experiments were performed in triplicate; error bars represent SD. *p < 0.0001.
See also Figure S1.
Figure 5. Active MLCK, S19-MLC2, Myosin IIA, and Myosin IIB Are
Recruited to Microdomains on the Chlamydial Inclusion
Recruitment of pY464- and pY471-phosphorylated MLCK, S19-phosphory-
lated MLC2, and myosin IIA and IIB were examined by indirect immunofluo-
rescence for colocalization with Src-pY419 in C. trachomatis-infected HeLa
cells at 18 hr postinfection with an MOI of 1. Representative images are
shown. Scale bar, 5 mm.Extrusion formation by C. trachomatis was monitored over
time to identify peak times of extrusion formation and release.
A peak of extrusion formation was seen at 48 hr postinfection
(Figure S1).1926 Cell Reports 3, 1921–1931, June 27, 2013 ª2013 The AuthorsC. trachomatis-infected cells were also treated with DMSO,
blebbistatin (myosin II inhibitor), or jasplakinolide (actin depoly-
merization inhibitor) and monitored for extrusion formation and
total inclusion-forming units (IFUs) at 48 hr postinfection. As
previously described (Hybiske and Stephens, 2007), blebbistatin
significantly inhibited extrusion formation (p < 0.0001) compared
with the jasplakinolide- or DMSO-treated cells (Figure S1). The
reduced extrusion formation was not due to growth inhibition,
since the total infectious plaque-forming units were constant
under all conditions.
The effects on the release mechanisms of C. trachomatis by
siRNA depletion of MLCK, MYPT1, MLC2, and myosin IIA and
IIB were assessed. The efficacy of siRNA knockdowns was
confirmed by QuantiGene analysis. All targeted messages
were decreased by >75%. Depletion of MYPT1 had no effect
on extrusion formation (Figure 6A). This result was not surprising
because it is the inactive, phosphorylated form of MYPT1 that is
associated with activation of the myosin motor complex, and
thus absence of MYPT1 is indistinguishable from its inactivation.
Figure 7. Schematic Representation of
the Myosin Phosphatase Pathway in
C. trachomatis Microdomains
The role of myosin phosphatase is to dephos-
phorylate MLC2. When phosphorylated at T853,
MYPT1 is inhibited and can no longer dephos-
phorylate MLC2. Src-family kinases (SFK) are
known to phosphorylate MLCK, which in turn
actively phosphorylatesMLC2.Myosin IIA, myosin
IIB, and phosphorylated MLC2 and MLCK are
required for C. trachomatis extrusion. Dashed
lines are used to present potential inhibitory
upstream regulators of MYPT1, including ROCK,
PP1, C-kinase potentiated protein phosphatase-1
inhibitor (CPI-17), PKCs, diacylglycerol (DAG), and
phospholipase C (PLC), that could contribute to
myosin phosphatase inhibition and chlamydial
extrusion.However, depletion of MLCK, MLC2, and myosin IIA and IIB
significantly reduced extrusion formation, suggesting that each
of these proteins was essential for C. trachomatis to produce
extrusions. Dual knockdowns of MYPT1 and MLCK produced
levels of extrusion events similar to those observed with MLCK
depletion alone. The extent of extrusion formation was not
dependent on total progeny IFUs, as C. trachomatis produced
similar levels of infectious progeny in all siRNA treatments (Fig-
ure 6B). The effects of MLCK, MYPT1, MLC2, MLCK and
MYPT1 combined, and myosin IIA and IIB depletion on dynein-
dependent interactions with the early inclusion were assessed
by two independent assays that were previously used to analyze
C. trachomatis inclusion trafficking (Mital and Hackstadt, 2011).
None of the depletions altered early trafficking of nascent inclu-
sions to theMTOCor the distance ofmature inclusions from cen-
trosomes (not shown). The interactions of the C. trachomatis
inclusion with the myosin phosphatase pathway and the actin
cytoskeleton do not appear to disrupt interactions with dynein
and microtubule-dependent trafficking.
DISCUSSION
In a yeast two-hybrid screen for Inc-interacting host proteins, an
interaction between the inclusion membrane protein CT228 and
a subunit of myosin phosphatase, MYPT1, was observed. The
recruitment of MYPT1 to the C. trachomatis inclusion was
confirmed and showed a unique pattern of circumferential
labeling of the inclusion membrane with enrichment at inclusion
membrane microdomains. The activity of MYPT1 is regulated by
the phosphorylation state (Amano et al., 1996). MYPT1 is phos-
phorylated by a number of kinases, including ROCK at T696 and
T853 (Feng et al., 1999; Kawano et al., 1999), protein kinase C
(PKC) at the ankyrin repeats (To´th et al., 2000), integrin-linked
kinase at T34 (Kiss et al., 2002), and Zip kinase at T695 (Hay-
stead, 2005). The T696 and T853 sites are inhibitory because
phosphorylation induces tertiary folding changes to MYPT1
that no longer allow for the binding of MLC2 and thus prevent
the dephosphorylation of MLC2. MLC2 thus remains in an active
state to interact with myosin IIA and myosin IIB to constitute an
active myosin motor complex. The recruitment of T853-phos-
phorylated MYPT1 to chlamydial inclusion microdomains sug-Cgests that myosin phosphatase would be in an inactive state at
these specific sites on the inclusion membrane. Accordingly,
the myosin phosphatase substrate, MLC2, was observed in
the S19-phosphorylated, active state within these Src-family
kinase-rich microdomains. MLCK is the kinase that phosphory-
lates MLC2 at T18 and S19; however, only recruitment of
pS19-MLC2 was addressed in our study. MLCK is activated by
phosphorylation at Y464 and Y471 (Birukov et al., 2001), and
recruitment of active MLCK to the chlamydial inclusion was
confirmed. The enrichment of active Src-family kinases at
C. trachomatis inclusion microdomains (Mital et al., 2010) sug-
gests that they play an important role in the phosphorylation
and activation of MLCK, thereby contributing to the phosphory-
lation ofMLC2 and the activation of themyosinmotor complex at
inclusionmembranemicrodomains. Recently, myosin was impli-
cated in one of the egress mechanisms of C. trachomatis, i.e.,
extrusion of intact inclusions from the host cell, rather than a lytic
event (Hybiske and Stephens, 2007). In this work, we confirmed
the recruitment of myosin IIA and myosin IIB to inclusion
membrane microdomains. A model depicting key elements of
the myosin regulatory pathway associated with the inclusion
membrane is shown in Figure 7. In this model, the antagonistic
activities of myosin phosphatase and myosin kinase would be
expected to shift the balance of lytic versus extrusion egress
mechanisms in response to external environmental stimuli and
appropriate cellular signaling pathways.
All intracellular pathogens must eventually exit the host
cell (Friedrich et al., 2012; Hybiske and Stephens, 2008).
C. trachomatis has evolved at least two (and possibly three)
distinct mechanisms of host-cell egress—cell lysis and extrusion
(Hybiske and Stephens, 2007)—and a nonlytic, exocytosis-like
mechanism (Todd and Caldwell, 1985). The extrusion mecha-
nism is an actin-dependent process that involves protrusion of
the inclusion from the host cell followed by constriction and
resealing of the plasma membrane and subsequent release of
the intact membrane-bound inclusion with survival of the host
cell. The extrusion mechanism is believed to be dependent on
actin polymerization, N-WASP, Rho GTPase, and myosin II
through the use of specific inhibitors of each of these activities
(Hybiske and Stephens, 2007). Recruitment of the actin coat to
the inclusion prior to extrusion appears to be a sporadic andell Reports 3, 1921–1931, June 27, 2013 ª2013 The Authors 1927
dynamic event that relies on a combination of both bacterial and
host factors (Chin et al., 2012).
C. trachomatismanipulates the myosin phosphatase pathway
throughout the course of its developmental cycle. MYPT1 asso-
ciates with CT228 at the inclusion membrane early and remains
throughout the developmental cycle. In this state, MYPT1 is not
phosphorylated and thus is an active MLC2 phosphatase that is
expected to favor inactive myosin motor complexes at the
inclusion membrane, which may prevent premature release of
inclusions from the cell. This is in contrast to the localized
enrichment of phosphorylated MYPT1 that occurs at discrete
microdomains late in infection. A comparison of HeLa cell lysates
from uninfected and infected cells shows an overall dephos-
phorylation of MYPT1 in the later stages of infection. Thus, the
majority of the phosphorylated, inactive MYPT1 is localized at
the inclusion membrane, where it appears to serve as focal point
at which activation of MLC2 by MLCK is favored and the myosin
motor complex is activated to promote egress of the intact
chlamydial inclusion. The manipulation of MYPT1 phosphoryla-
tion by C. trachomatis not only limits active myosin complexes
in the host cell but also permits selective exploitation of active
myosin motor complexes by Chlamydia for egress.
Recruitment of MYPT1 among the different chlamydial spe-
cies and serovars can be at least partially accounted for by the
diversity of CT228. C. trachomatis serovar B/Jali20 encodes a
truncated CT228 (Seth-Smith et al., 2009). Specifically, a dele-
tion at position 86 of CT228 results in a frameshift that is pre-
dicted to produce a truncated CT228 (38 aa long) lacking the C
terminus that interacts with the leucine zipper of MYPT1. We
confirmed the lack of expression with specific antibodies.
Accordingly, C. trachomatis B/Jali20 does not recruit MYPT1
to the inclusion membrane. Interestingly, C. trachomatis B/
Jali20 did not form extrusions (not shown). The most closely
related species to C. trachomatis that also recruited MYPT1,
C. muridarum, contains a CT228 homolog that shares 50% iden-
tity at the amino acid level to CT228 of C. trachomatis L2.
However, C. muridarum does not exhibit Src-kinase-rich micro-
domains (Mital et al., 2010).C. caviae andC. pneumoniae did not
recruit MYPT1. C. caviae contains a distant homolog that may
be too divergent to have retained the same function, and
C. pneumoniae lacks a CT228 homolog (Lutter et al., 2012). It
is likely that additional chlamydial or host factors, possibly those
involved in the initiation of actin recruitment around the late inclu-
sion (Hybiske and Stephens, 2007; Kumar and Valdivia, 2008),
are required for the commencement of the actual extrusion
process. Interestingly, neither MYPT1 nor inclusion membrane
microdomains (Mital et al., 2010) are observed in C. caviae,
although C. caviae has been described as utilizing the extrusion
mechanism of release, albeit at an apparently reduced rate
(Hybiske and Stephens, 2007). The recognition of Chlamydia
variants lacking CT228 and/or Src-kinase-rich microdomains
should be of value in deciphering the many potential regulatory
pathways that control C. trachomatis egress from infected cells.
Modulation of MLC2 andMLCK phosphorylation states during
the infection process of other pathogens has been described.
MYPT1 had not been previously reported to be recruited to the
site of infection of other intracellular pathogens, although
changes in phosphorylation of MYPT1 were identified during1928 Cell Reports 3, 1921–1931, June 27, 2013 ª2013 The AuthorsTrypanosoma cruzi infection (Mott et al., 2009). Evidence of
MLC2 phosphorylation during infection of enteropathogenic
E. coli (EPEC) was observed in cell fractions associated with
the cytoskeleton (Manjarrez-Hernandez et al., 1996). Alterations
in intestinal epithelial cell permeability induced by either EPEC or
enterohemorrhagic E. coli involve the phosphorylation of MLCK
(Philpott et al., 1998; Yuhan et al., 1997). Myosin is a known
target for other intracellular pathogens, including Listeria mono-
cytogenes, which usurps myosin VIIA for uptake into host cells
(Sousa et al., 2004), and Shigella flexneri, which requires myosin
II (Rathman et al., 2000) for dissemination and myosin-X for filo-
podia formation (Bishai et al., 2013). The Salmonella enterica
serovar Typhimurium also co-opts myosin II via SopB to regulate
salmonella-containing vacuole dynamics such as positioning
and stability (Wasylnka et al., 2008). Several viruses (Santangelo
and Bao, 2007; van Leeuwen et al., 2002) also utilize myosin in
egress from host cells, although these viruses are not located
in a membrane-bound compartment.
C. trachomatis inclusion membrane microdomains were first
identified as areas of focal recruitment of activated Src-family
tyrosine kinases and the microtubular cytoskeleton (Mital et al.,
2010). It now appears that microdomains are also focal points
for interactions with the actin cytoskeleton and involvement in
egress at the end of the developmental cycle. Inclusion mem-
branemicrodomains thus appear to be platforms for interactions
with both the actin and microtubular cytoskeletons. Whether the
two pathways interact cooperatively or antagonistically remains
to be determined. The fact that Src-family tyrosine kinases and
early expressed Incs have been implicated in the regulation of
both early trafficking of the inclusion and egress suggests that
antagonistic activities may hold egress mechanisms in check
until an appropriate signal is received at the end of the develop-
mental cycle. Tyrosine phosphorylation seems to play multiple,
species-specific roles in early versus late interactions with the
cytoskeleton throughout the chlamydial developmental cycle
(Mital and Hackstadt, 2011) andmay be a key regulator of egress
mechanisms.
It is interesting that chlamydiae would have two independent
means of egress. It is suspected that the underlying purpose of
chlamydial extrusion may lie in evasion of innate or acquired
immune responses (Hybiske and Stephens, 2007). The release
of infectious EBs encapsulated within an intact inclusion mem-
brane may allow the chlamydiae to evade local inflammatory
mediators for subsequent release and infection of susceptible
cells at more distal sites. Interestingly, two potential upstream
regulators of the myosin phosphatase pathway, PKC and
ROCK, are activated by pathways involved in immune responses
and inflammation. Activation of PKC and extracellular signal-
related kinases (ERKs) during EPEC infection of intestinal epithe-
lial cells leads to activation of NF-kB and the proinflammatory
response (Savkovic et al., 2003). In addition, endothelial cell
permeability is increased by LPS and tumor necrosis factor alpha
(TNF-a), which activate p38 and ERK1/2 mitogen-activated pro-
tein kinases, increase NF-kB signaling and ROCK-mediated
phosphorylation of MYPT1, and lead to the accumulation of
phosphorylated MLC2 (Xing and Birukova, 2010). The upstream
events leading to the phosphorylation of MYPT1 and MLC2 at
the chlamydial inclusion microdomains remain to be verified,
but activation of upstream regulators of themyosin phosphatase
pathway during an immune or inflammatory response to
chlamydial infection would be expected to shift the mechanism
of host-cell exit to favor extrusion. The dissemination of mem-
brane-bound infectious EBs to distant sites to avoid exposure
to the harsh environment of local inflammatory responses would
thus be favored. Future characterization of the pathway and
regulatory components should provide insights leading to a
greater understanding of how C. trachomatis forms extrusions
and the role it plays in chlamydial pathogenesis.
EXPERIMENTAL PROCEDURES
Strains and Cell Culture
The C. trachomatis serovars L2 (LGV 434), D (UW3-Cx), B (Jali20/OT), and A
(HAR-13); C. muridarum (MoPn); C. pneumoniae (AR-39); and C. caviae
(GPIC) were propagated in HeLa 229 cells and purified by Renografin density
gradient centrifugation as previously described (Caldwell et al., 1981). HeLa
229 cells were grown in RPMI 1640 medium with 10% fetal bovine serum
(FBS). Yeast strain Y187 was purchased from Clontech, and AH109 was
provided by M.A. Scidmore.
Antibodies
Monoclonal antibody L2-I-45 againstC. trachomatis L2major outer membrane
protein (MOMP) was kindly provided by H.D. Caldwell. GAL4-DNA BD fusions
of CT228 were detected with Myc antibody (Cell Signaling). Anti-MYPT1
(United States Biological) and anti-T853 MYPT1 (Abnova) were used to detect
pan-MYPT1 and Thr-853-phosphorylated MYPT1 by indirect immunofluores-
cence. Anti-MYPT1, anti-pT853 MYPT1, anti-pT696 MYPT1, anti-Myc, and
anti-glyceraldehyde 3-phosphate dehydrogenase (Cell Signaling) were used
for immunoblotting. Anti-phospho (pSer-19)-MLC2 was purchased from
Abcam. Anti-Src-pTyr419 (clone 9A6; Millipore) was used to detect active
Src-family kinases. Anti-14-3-3b (clone H8), anti-MLCK (pTyr471), and
anti-MLCK (pTyr464) were purchased from Santa Cruz Biotechnology. Anti-
Chlamydia LPS (Thermo Scientific) was used to detect all species of chla-
mydiae, and a rabbit polyclonal anti-EB serum was used to detect
C. trachomatis. Anti-myosin IIA and anti-myosin IIB were purchased from
Thermo Scientific. Anti-mouse or anti-rabbit DyLight 594 and DyLight 488
(Jackson ImmunoResearch Laboratories) were used as secondaries for indi-
rect immunofluorescence, and horseradish peroxidase (HRP)-conjugated
donkey anti-rabbit immunoglobulin G (IgG) and anti-mouse IgG (Jackson
ImmunoResearch Laboratories) were used for immunoblotting and immunoe-
lectron microscopy as previously described (Scidmore-Carlson et al., 1999).
CT228 Antibody Production
Overnight cultures of BL21 (DE3) were subcultured at 1:200 in 600 ml of Luria-
Bertani broth and grown tomid-exponential phase at 37C.CT228-His expres-
sion was induced by addition of isopropyl-1-thio-b-D-galactopyranoside
(IPTG) to a final concentration of 1 mM, with a further 4 hr of growth at 37C.
The culture was harvested by centrifugation at 5,000 rpm for 10 min and pro-
tein purification was carried out using the ProBond Purification System (Life
Technologies) according to the manufacturer’s instructions. Purified protein
was quantitated using the Bradford protein assay (Bio-Rad) and dialyzed
overnight against 100 mM NaCl. The purified protein was emulsified in Sigma
Adjuvant System (Sigma) and rabbits were immunized according to the
manufacturer’s instructions.
Yeast Two-Hybrid Library Screening
Yeast two-hybrid assays were performedwith the use of theMatchmaker Gold
yeast two-hybrid system (Clontech). The Y187 yeast strain, pretransformed
with Normalized Mate and Plate HeLa S3 Library constructed in pGADT7-
RecAB, was purchased from Clontech. pGBKT7-CT228 was transformed
into AH109 and mated overnight with Y187 containing Normalized Mate
and Plate HeLa S3 Library. Matings were screened for interacting clones by
selecting diploids on SD plates lacking leucine (Leu), tryptophan (Trp), andChistidine (His) (low stringency). Positive diploids were rescreened for the ability
to grow on SD plates lacking His, Leu, Trp, and adenine (Ade) + X-a galacto-
sidase (high stringency). Plasmid DNA was isolated from blue diploid colonies
using the PrepEase Yeast Plasmid Isolation Kit (Affymetrix), transformed into
E. coli XL1-blue (Stratagene), re-extracted using a QIAGEN plasmid extraction
kit, and sequenced at RML Genomics, Research Technologies Section,
National Institute of Allergy and Infectious Diseases. Bait dependencies and
targeted screens were performed by directed mating between AH109 carrying
pGBKT7-CT228 and Y187 carrying prey plasmids from selected diploids.
Matings were plated on high-stringency plates and monitored for diploid
growth. See the Extended Experimental Procedures for a detailed description
of plasmid construction.
Protein Preparation and Western Blotting
Protein extracts from AH109 carrying pGBKT7-CT228 were prepared accord-
ing to the urea/SDS protein extraction method provided in the Yeast Protocols
Handbook (Clontech) prior to SDS-PAGE and electrophoretic transfer to nitro-
cellulose. HeLa cells were infected withC. trachomatis at amultiplicity of infec-
tion (moi) of 1. At appropriate times postinfection, the cells were rinsed in
PBS (pH 7.4) and lysed in Laemmli buffer (Laemmli, 1970) with 5% b-mercap-
toethanol plus PhosSTOP inhibitor cocktail (Roche) and Complete Mini
protease inhibitor cocktail (Roche). Protein extracts and cell lysates were
separated by SDS-PAGE and transferred to nitrocellulose. Membranes were
blocked in 5% nonfat dry milk/2% BSA in 50 mM Tris-HCl (pH 7.4), 150 mM
NaCl, 0.1% Tween 20 (TBS-T) and incubated with protein-specific primary
antibody in blocking buffer overnight. Unbound antibody was removed by
three rinses in TBS-T, and bound antibody was detectedwith HRP-conjugated
donkey anti-rabbit IgG secondary. Blots were then rinsed three times in TBS-T
and developed with Amersham ECL selection western blotting detection
reagent (GE Healthcare Life Sciences) and exposed to CL-XPosure film
(Thermo Scientific).
siRNA Knockdown
Monolayers of HeLa 229 cells (50% confluence) were plated on glass
coverslips or Costar CellBIND (Corning) 24-well plates and incubated
overnight with MYPT1, MLC2, myosin IIA, myosin IIB, MLCK, or Scramble
Targetplus Smartpool siRNA (Dharmacon) complexed in DharmaFECT1 in
RPMI with 10% FBS. At 72 hr posttransfection, cells were infected with
C. trachomatis L2 at an MOI of 1 for 48 hr. Knockdown efficiency based
upon transcript level was determined by QuantiGene analysis (Panomics)
per the manufacturer’s instructions. Lysates were probed with MYPT1,
MLC2, myosin IIA, myosin IIB, MLCK, or actin-specific RNA probes, and the
luminescence for each sample and probe was measured using a Synergy4
plate reader (BioTek Instruments). Each transcript was normalized to the actin
signal as a loading control.
Coimmunoprecipitation
HeLa cells were either mock infected or infected with C. trachomatis L2. At
48 hr postinfection, the cells were washed three times with PBS, scraped
into 0.75 ml of RIPA buffer plus PhosSTOP inhibitor cocktail (Roche) and
Complete Mini protease inhibitor cocktail (Roche), and incubated for 20 min
on ice. Cell debris was removed by centrifugation (13,000 rpm, 5 min, 4C).
Cell-free lysates were incubated with anti-CT228 or anti-Rickettsia for 1 hr
with rotation at 4C. Protein-A beads (Thermo Scientific) were added and
rotation continued overnight at 4C. The beads were washed three times
with PBS and bound proteins were eluted into Laemmli buffer (Laemmli,
1970) with 5% b-mercaptoethanol, separated by SDS-PAGE, and electropho-
retically transferred to nitrocellulose for detection with MYPT1 antibody.
Infectious Progeny and Inclusion Development Assays
Following siRNA knockdown and 48 hr of C. trachomatis L2 infection, both
supernatant and cell lysates were examined for IFUs. Supernatant and cells
lysed in distilled water were serially diluted in Hank’s balanced salt solution
and plated onto HeLa cell monolayers. After 24 hr of infection, monolayers
were fixed in methanol and stained with rabbit anti-EB sera followed by anti-
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on 20 fields for each sample using a Nikon Eclipse 80i fluorescent microscope.
Total IFUs/ml were calculated for each sample.
Extruded Inclusion Enumeration
Extruded inclusions were enumerated by amethod similar to that described by
Chin et al. (2012). HeLa cells were infected with C. trachomatis L2 at an MOI
of 1. At 24 hr postinfection, the medium was replaced with RPMI 1640
medium with 10% FBS supplemented with DMSO, blebbistatin (50 mM;
EMD Millipore), or jasplakinolide (1 mM; Life Technologies). At the indicated
times, the supernatants were removed and gently pelleted by centrifugation
at 1,000 rpm. The resulting pellet was resuspended in 100 ml of media, mixed
with trypan blue (Life Technologies), and stained with NucBlue Hoechst
live-cell stain (Life Technologies). Extruded inclusions free of host cell nuclei
were enumerated using a Hausser Bright-line Phase hemacytometer and a
Zeiss LSM 510 Meta laser confocal scanning microscope.
Statistics
Statistical analysis was performed in Prism 5.0 using a one-way ANOVA and a
Newman-Keuls posttest.
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